These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6506859)

  • 21. Human malignancy-associated nucleolar antigen (HuMANA) and zinc in human prostatic tissues.
    Gyorkey F
    Prog Clin Biol Res; 1981; 75A():491-502. PubMed ID: 7041135
    [No Abstract]   [Full Text] [Related]  

  • 22. [New data on relations between residual hormonal modulability and medical treatment of breast adenocarcinoma].
    Prodi G; Lollini PL; Nicoletti G
    Minerva Med; 1984 Feb; 75(6):219-21. PubMed ID: 6709205
    [No Abstract]   [Full Text] [Related]  

  • 23. Predicting the response of prostatic carcinoma to endocrine therapy.
    Ghanadian R; Auf G; Williams G; Davis A; Richards B
    Lancet; 1981 Dec 19-26; 2(8260-61):1418. PubMed ID: 6118783
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Steroid hormone receptors in kidney cancer tissue].
    Smirnova KD; Bassalyk LS; Bukharkin BV; Murav'eva NI; Kuz'mina ZV
    Urol Nefrol (Mosk); 1984; (5):3-5. PubMed ID: 6506382
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
    Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid receptors in prostate neoplasms.
    Robel P; Hechter O
    Prog Clin Biol Res; 1983; 132E():175-82. PubMed ID: 6647467
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunoreactivity of ubiquitin in human prostate gland.
    Bataineh ZM; Habbal O
    Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma.
    Arcuri F; Cintorino M; Florio P; Floccari F; Pergola L; Romagnoli R; Petraglia F; Tosi P; Teresa Del Vecchio M
    Prostate; 2002 Aug; 52(3):167-72. PubMed ID: 12111693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic carcinoma producing syndrome of inappropriate secretion of antidiuretic hormone.
    Sacks SA; Rhodes DB; Malkasian DR; Rosenbloom AA
    Urology; 1975 Oct; 6(4):489-92. PubMed ID: 1179573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
    Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of glycerol phosphoryl ethanolamine in human adenocarcinomatous prostate tissue.
    van Sande M; Van Camp K
    J Urol; 1979 Jan; 121(1):133. PubMed ID: 83393
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cytoplasmic steroid hormone receptors in primary breast tumors].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Vishniakova VV
    Vopr Onkol; 1982; 28(4):6-10. PubMed ID: 7090272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenoid cyst-like carcinoma of the prostate gland.
    Cohen RJ; Goldberg RD; Verhaart MJ; Cohen M
    Arch Pathol Lab Med; 1993 Aug; 117(8):799-801. PubMed ID: 8343043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of tumor response to endocrine therapy in prostatic carcinoma based on steroid receptor assay.
    Ekman P; Gustafsson JA; Högberg B; Pousette A; Snochowski M
    Scand J Urol Nephrol Suppl; 1980; 55():83-9. PubMed ID: 6938041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Steroid hormone receptors in benign and malignant breast and uterine tumors].
    Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Sharoukhova KS
    Vestn Akad Med Nauk SSSR; 1980; (6):82-4. PubMed ID: 7405386
    [No Abstract]   [Full Text] [Related]  

  • 40. Androgen receptors in prostate cancer.
    White RD; Olsson CA
    Urology; 1981 Apr; 17(4 Suppl):24-6. PubMed ID: 7193939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.